SCHEMBL3265134

SCHEMBL3265134

CCc1noc(C(C)(C)C)c1CC

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.30
BLM P54132 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14793712 0.78 LMNA (0.31) HIF1ABLM
SCHEMBL2337141 0.77 HIF1A (0.32) HIF1ABLM
SCHEMBL8266990 0.70 NPSR1 (0.37)
SCHEMBL11311293 0.70 P2RX7 (0.37)
SCHEMBL16935024 0.65 NOS2 (0.34) HIF1ABLM
SCHEMBL15292224 0.65 NPSR1 (0.34)
SCHEMBL17464658 0.65 PTGS1 (0.32)
SCHEMBL17761985 0.65 NR1H4 (0.32)
SCHEMBL22951369 0.64
SCHEMBL22861186 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120004196-A1 Anti-Viral Compounds Abbott Labaoratories (US) 2012-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120004196-A1 Anti-Viral Compounds HAVCR2, EIF2AK2, MAVS HIF1A 1619/4885BLM 1906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.